Anisaxins, helical antimicrobial peptides from marine parasites, kill resistant bacteria by lipid extraction and membrane disruption.


Journal

Acta biomaterialia
ISSN: 1878-7568
Titre abrégé: Acta Biomater
Pays: England
ID NLM: 101233144

Informations de publication

Date de publication:
01 07 2022
Historique:
received: 17 11 2021
revised: 12 04 2022
accepted: 14 04 2022
pubmed: 27 4 2022
medline: 15 6 2022
entrez: 26 4 2022
Statut: ppublish

Résumé

An infecting and propagating parasite relies on its innate defense system to evade the host's immune response and to survive challenges from commensal bacteria. More so for the nematode Anisakis, a marine parasite that during its life cycle encounters both vertebrate and invertebrate hosts and their highly diverse microbiotas. Although much is still unknown about how the nematode mitigates the effects of these microbiota, its antimicrobial peptides likely play an important role in its survival. We identified anisaxins, the first cecropin-like helical antimicrobial peptides originating from a marine parasite, by mining available genomic and transcriptomic data for Anisakis spp. These peptides are potent bactericidal agents in vitro, selectively active against Gram-negative bacteria, including multi-drug resistant strains, at sub-micromolar concentrations. Their interaction with bacterial membranes was confirmed by solid state NMR (ssNMR) and is highly dependent on the peptide concentration as well as peptide to lipid ratio, as evidenced by molecular dynamics (MD) simulations. MD results indicated that an initial step in the membranolytic mode of action involves membrane bulging and lipid extraction; a novel mechanism which may underline the peptides' potency. Subsequent steps include membrane permeabilization leading to leakage of molecules and eventually cell death, but without visible macroscopic damage, as shown by atomic force microscopy and flow cytometry. This membranolytic antibacterial activity does not translate to cytotoxicity towards human peripheral blood mononuclear cells (HPBMCs), which was minimal at well above bactericidal concentrations, making anisaxins promising candidates for further drug development. STATEMENT OF SIGNIFICANCE: Witnessing the rapid spread of antibiotic resistance resulting in millions of infected and dozens of thousands dying worldwide every year, we identified anisaxins, antimicrobial peptides (AMPs) from marine parasites, Anisakis spp., with potent bactericidal activity and selectivity towards multi-drug resistant Gram-negative bacteria. Anisaxins are membrane-active peptides, whose activity, very sensitive to local peptide concentrations, involves membrane bulging and lipid extraction, leading to membrane permeabilization and bacterial cell death. At the same time, their toxicity towards host cells is negligible, which is often not the case for membrane-active AMPs, therefore making them suitable drug candidates. Membrane bulging and lipid extraction are novel concepts that broaden our understanding of peptide interactions with bacterial functional structures, essential for future design of such biomaterials.

Identifiants

pubmed: 35470073
pii: S1742-7061(22)00234-3
doi: 10.1016/j.actbio.2022.04.025
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Antimicrobial Cationic Peptides 0
Antimicrobial Peptides 0
Lipids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

131-144

Informations de copyright

Copyright © 2022 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Tomislav Rončević (T)

Department of Biology, Faculty of Science, University of Split, Ruđera Boškovića 33, Split 21000, Croatia. Electronic address: troncevic@pmfst.hr.

Marco Gerdol (M)

Department of Life Sciences, University of Trieste, Trieste 34127, Italy.

Mario Mardirossian (M)

Department of Medical Sciences, University of Trieste, Trieste 34125, Italy.

Matko Maleš (M)

Faculty of Maritime Studies, University of Split, Split 21000, Croatia.

Svjetlana Cvjetan (S)

Laboratory for Aquaculture, Institute of Oceanography and Fisheries, Split 21000, Croatia.

Monica Benincasa (M)

Department of Life Sciences, University of Trieste, Trieste 34127, Italy.

Ana Maravić (A)

Department of Biology, Faculty of Science, University of Split, Ruđera Boškovića 33, Split 21000, Croatia.

Goran Gajski (G)

Mutagenesis Unit, Institute for Medical Research and Occupational Health, Zagreb 10000, Croatia.

Lucija Krce (L)

Department of Physics, Faculty of Science, University of Split, Split 21000, Croatia.

Ivica Aviani (I)

Department of Physics, Faculty of Science, University of Split, Split 21000, Croatia.

Jerko Hrabar (J)

Laboratory for Aquaculture, Institute of Oceanography and Fisheries, Split 21000, Croatia.

Željka Trumbić (Ž)

University Department of Marine Studies, University of Split, Split 21000, Croatia.

Maik Derks (M)

NMR spectroscopy, Bijvoet Centre for Biomolecular Research, University of Utrecht, Utrecht 3584CH, The Netherlands; Membrane Biochemistry and Biophysics, Bijvoet Centre for Biomolecular Research, Department of Chemistry, Utrecht University, Padualaan 8, Utrecht 3584 CH, The Netherlands.

Alberto Pallavicini (A)

Department of Life Sciences, University of Trieste, Trieste 34127, Italy; Oceanography Division, Istituto Nazionale di Oceanografia e di Geofisica Sperimentale - OGS, Trieste, Italy.

Markus Weingarth (M)

NMR spectroscopy, Bijvoet Centre for Biomolecular Research, University of Utrecht, Utrecht 3584CH, The Netherlands.

Larisa Zoranić (L)

Department of Physics, Faculty of Science, University of Split, Split 21000, Croatia.

Alessandro Tossi (A)

Department of Life Sciences, University of Trieste, Trieste 34127, Italy.

Ivona Mladineo (I)

Laboratory of Functional Helminthology, Biology Centre Czech Academy of Sciences, Institute of Parasitology BC CAS, Branisovska 31, Ceske Budejovice 37005, Czech Republic. Electronic address: ivona.mladineo@paru.cas.cz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH